Drug-price Transparency for Consumers Act of 2025 or the DTC Act of 2025 This bill requires consumer advertisements for prescription drugs and biological products to include certain price information if the drug or biologic is (1) covered under Medicare or Medicaid, and (2) required to include a risk summary under current law. Specifically, such advertisements must clearly and conspicuously disclose the wholesale price for a 30-day supply of the drug or biologic and may explain that a consumer may pay a different amount for the drug or biologic depending on the consumer's health insurance coverage. The requirement does not apply to advertisements for drugs or biologics with a wholesale cost of less than $35 for a one-month supply. Each violation of this requirement is subject to a civil penalty of not more than $100,000.
Read twice and referred to the Committee on Finance. (text: CR S337-338; Sponsor introductory remarks on measure: CR S337)
Bill introduced
Lobbying filed by AARP
Lobbying filed by AMERICAN HOSPITAL ASSOCIATION
Lobbying filed by AMERICA'S HEALTH INSURANCE PLANS INC (AHIP)
Lobbying filed by AMERICAN HOSPITAL ASSOCIATION
Read twice and referred to the Committee on Finance. (text: CR S337-338; Sponsor introductory remarks on measure: CR S337)
| Registrant | Client | Amount | Filed | Period | Issues |
|---|---|---|---|---|---|
| AMERICAN HOSPITAL ASSOCIATION | AMERICAN HOSPITAL ASSOCIATION | $7.0M | Apr 21, 2025 | 2025Q1 | MMMHCRBUD |
| AARP | AARP | $6.6M | Apr 18, 2025 | 2025Q1 | HCRMMMAGR |
| AMERICAN HOSPITAL ASSOCIATION | AMERICAN HOSPITAL ASSOCIATION |
The lobbying table lists Senate LDA quarterly reports (LD-2) that cite this bill by number and cover a quarter of the 119th Congress. An LD-2 names a bill as “H.R. 1234” with no Congress, so a report on another Congress, which can only concern a different bill with the same number, is left out, even when it was filed after this Congress began. The amount is what the registrant reported for the whole filing, across every issue on it, not spending on this bill. Official actions and the bill summary come from Congress.gov, and votes from the roll-call record. This page no longer pairs the bill with members' stock trades: matching lobbying clients to traded companies by name, and trades to a bill by date, is not something the records establish.
Lobbying filed by AARP
| $6.2M |
| Jul 21, 2025 |
| 2025Q2 |
MMMHCRBUD |
| AARP | AARP | $5.1M | Jul 21, 2025 | 2025Q2 | MMMHCRPHA |
| AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP) | AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) | $4.8M | Apr 21, 2025 | 2025Q1 | HCRMMMINS |
| AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP) | AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) | $4.0M | Jul 21, 2025 | 2025Q2 | HCRMMMINS |
| PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION | PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION | $3.4M | Jul 21, 2025 | 2025Q2 | MMMHCRPHA |
| AMERICAN ACADEMY OF FAMILY PHYSICIANS | AMERICAN ACADEMY OF FAMILY PHYSICIANS | $1.2M | Jul 16, 2025 | 2025Q2 | BUDEDUHCR |
| AMERICAN ACADEMY OF FAMILY PHYSICIANS | AMERICAN ACADEMY OF FAMILY PHYSICIANS | $1.1M | Apr 15, 2025 | 2025Q1 | BUDEDUHCR |
| MEHLMAN CONSULTING, INC. | THE CAMPAIGN FOR SUSTAINABLE RX PRICING | $90.0K | Jul 21, 2025 | 2025Q2 | MMMPHACPT |
| MEHLMAN CONSULTING, INC. | THE CAMPAIGN FOR SUSTAINABLE RX PRICING | $90.0K | Apr 17, 2025 | 2025Q1 | MMMPHACPT |
| WHITMER & WORRALL, LLC | CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) | $50.0K | Jul 21, 2025 | 2025Q2 | MMMCPTPHA |
| WHITMER & WORRALL, LLC | CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) | $50.0K | Apr 21, 2025 | 2025Q1 | MMMCPTPHA |
| COALITION FOR HEALTHCARE COMMUNICATIONS | COALITION FOR HEALTHCARE COMMUNICATIONS | Undisclosed | Aug 5, 2025 | 2025Q2 | HCR |